Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors.
Nishimura T, Velaga R, Masuda N, Kawaguchi K, Kawaguchi S, Takada M, Maeshima Y, Tanaka S, Kikawa Y, Kadoya T, Bando H, Nakamura R, Yamamoto Y, Ueno T, Yasojima H, Ishiguro H, Morita S, Ohno S, Haga H, Matsuda F, Ogawa S, Toi M.
Nishimura T, et al. Among authors: ishiguro h.
Cancer Sci. 2024 Oct 7. doi: 10.1111/cas.16339. Online ahead of print.
Cancer Sci. 2024.
PMID: 39375938
Free article.